| Calbindin D-28k |
|---|
| Protein Name | Calbindin |
| Gene | CALB1 |
| UniProt ID | P05937 |
| PDB ID | 1IG5 |
| Molecular Weight | 30 kDa |
| Localization | Cytosol |
| Protein Family | EF-hand calcium-binding proteins |
Calbindin D-28k (encoded by the CALB1 gene) is a calcium-binding protein of the EF-hand family with a molecular weight of approximately 30 kDa. It is widely expressed in neurons throughout the central nervous system, particularly in Purkinje cells of the cerebellum, hippocampal pyramidal neurons, and various cortical neuronal populations.
Calbindin serves as a high-affinity calcium buffer, protecting neurons from calcium overload and excitotoxicity. It is one of the most studied calcium-binding proteins in the context of neurodegeneration.
Calbindin D-28k possesses:
- 6 EF-hand calcium-binding motifs
- High-affinity calcium binding (Kd ~10^-7 M)
- Characteristic EF-hand protein fold
- Dimerization capability
- Structure solved by X-ray crystallography (PDB: 1IG5)
Calbindin functions as a neuroprotective calcium buffer:
- Protects neurons from excitotoxicity
- Modulates intracellular calcium kinetics
- Prevents mitochondrial calcium overload
- Shapes synaptic plasticity
Calbindin provides neuroprotection through:
- Buffering excessive calcium influx
- Regulating calcium-dependent signaling pathways
- Protecting against oxidative stress
- Maintaining mitochondrial function
Calbindin modulates synaptic function:
- Regulates long-term potentiation (LTP)
- Affects synaptic vesicle cycling
- Influences GABAergic signaling
- Modulates network oscillations
Calbindin D-28k has been extensively studied in Alzheimer's disease:
-
Early Marker: Loss of calbindin is an early marker of neuronal dysfunction
-
Selective Vulnerability: Calbindin+ neurons show relative resistance to amyloid-beta toxicity
-
Mechanisms of Protection:
- Enhanced calcium homeostasis
- Reduced mitochondrial dysfunction
- Lower oxidative stress response
- Resistance to apoptotic signals
-
Therapeutic Interest: Calbindin restoration is a potential therapeutic strategy
In Parkinson's disease:
- Calbindin expression correlates with dopaminergic neuron vulnerability
- Vulnerable substantia nigra pars compacta neurons have low calbindin
- Calbindin+ neurons in the basal ganglia show relative preservation
- Potential role in alpha-synuclein pathology
Calbindin alterations in Huntington's disease:
- Reduced calbindin in striatal neurons
- Correlation with disease progression
- Affected medium spiny neuron populations
- Amyotrophic Lateral Sclerosis (ALS): Variable expression changes
- Epilepsy: Altered calbindin in seizure models
- Stroke: Protective role in ischemic injury
Calbindin has significant therapeutic potential:
- Gene Therapy: Viral delivery of CALB1 to protect neurons
- Small Molecule Mimetics: Developing calbindin-mimetic compounds
- Cell-Based Therapy: Transplantation of calbindin-expressing cells
- Biomarker: Calbindin as a marker for neuronal health
Calbindin is widely used as a neuronal marker:
- Immunohistochemistry: Primary marker for specific neuron populations
- Transgenic Reporter Lines: For studying neuronal development
- Electrophysiology: Studying calcium dynamics in calbindin+ neurons
- Single-cell RNA-seq: Marker for neuronal classification
¶ Interactions and Pathways
Calbindin interacts with:
- Calcium-dependent signaling proteins
- Mitochondrial calcium uniporter (MCU)
- Calmodulin-dependent kinases
- Transcription factors
- Baimbridge et al. (1992). Calbindin-D28k and calcium signaling. Prog Neurobiol.
- Mattson et al. (1991). Calcium-binding protein neuroprotection. J Neurosci Res.
- Heizmann & Braun (1992). Calcium binding proteins. Trends Neurosci.
- Winsky & Kuznicki (1995). Distribution of calbindin. J Comp Neurol.
- German et al. (1992). Calbindin in substantia nigra. Exp Neurol.
- Iacopino et al. (1992). Calbindin and excitotoxicity. Brain Res Mol Brain Res.